A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

BACKGROUND: There is a continued need to develop more effective cancer immunotherapy strategies. Exosomes, cell-derived lipid vesicles that express high levels of a narrow spectrum of cell proteins represent a novel platform for delivering high levels of antigen in conjunction with costimulatory mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Morse, Michael A, Garst, Jennifer, Osada, Takuya, Khan, Shubi, Hobeika, Amy, Clay, Timothy M, Valente, Nancy, Shreeniwas, Revati, Sutton, Mary Ann, Delcayre, Alain, Hsu, Di-Hwei, Le Pecq, Jean-Bernard, Lyerly, H Kim
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551593/
https://www.ncbi.nlm.nih.gov/pubmed/15723705
http://dx.doi.org/10.1186/1479-5876-3-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551593/
https://www.ncbi.nlm.nih.gov/pubmed/15723705
http://dx.doi.org/10.1186/1479-5876-3-9

Ejemplares similares